Vertex Pharmaceuticals announced the FDA has accepted its biologics license application submission for povetacicept, an ...
Generic drugmakers just got a major win at the Supreme Court. In a unanimous ruling, the justices sided with Hikma in a patent fight over its “skinny label” generic version of Amarin’s heart drug ...
U.S. health secretary Robert F. Kennedy Jr. is pursuing federal government access to most Americans’ medical records, in a ...
If the feedback from this year’s Women of Distinction ceremony is any indication, those who attended left with their cup ...
We now have more data on when and how patients are searching for health information on LLMs. Marketers should keep this in ...
The FDA's Office of Prescription Drug Promotion issued an untitled letter to QOL Medical over two promotional emails for ...
Healthline AI launches first in type 2 diabetes content, with Fullspan pitching the tool as a clinically guarded way to ...
The Trump administration’s rollout of a federal mandate that millions of Americans on Medicaid must work or risk losing ...
Hundreds of detainees across at least 33 states allege in federal suits that immigration detention facilities are failing to ...
FDA issues industry-friendly gene therapy guidance; Eli Lilly demands claims data from some 340B hospitals; Fast-tracking a ...
Fractyl Health appointed Mike Zumdahl as SVP of market access and commercial strategy. Healthtech AI company Briya hired ...
Read is not the first former agency group CEO to launch a technology-focused conference. Maurice Lèvy, the emeritus chairman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results